NanoSTING-001

N/A

Report date: 2024/12/02 17:16:19

Base Information

Drug NameNanoSTING-001
Drug Alias NameNanoSTING-001
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAuraVax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAuraVax Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRespirovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A